Abstract
In contrast to frog neuromuscular synapses, where noradrenaline (norepinephrine) and its analogues caused synchronization of the acetylcholine release process, in mouse diaphragm endplates noradrenaline increased the degree of asynchrony of neurosecretion. The effect of noradrenaline on release timing persisted at different levels of external calcium ions (0.25–2.0 mM) and was abolished in presence of both α- and β‑adrenoblockers phentolamine and propranolol. The computer reconstruction of multiquantal endplate currents accounting for experimentally observed modification of release kinetics under noradrenaline showed that the rise time of postsynaptic response changes to a greater extent than the amplitude and falling phase of the multiquantal responses. We conclude that there exists a principal difference in the action of noradrenaline in the cholinergic neuromuscular synapses of warm-blooded and cold-blooded animals that can be accounted for by the differences in the type of adrenoreceptors involved in the modulation of synaptic transmission and/or in the involvement of distinct intracellular pathways triggered by receptor activation.
Similar content being viewed by others
REFERENCES
Bowman W., Nott M. 1969. Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol. Rev. 21, 27–72.
Fellenius E., Hedberg R., Holmberg E., Waldeck B. 1980. Functional and metabolic effects of terbutaline and propranolol in fast- and slow-contracting skeletal muscle in vitro. Acta Physiol. Scand. 109, 89–95.
Cairns S., Borrani, F. 2015. β-Adrenergic modulation of skeletal muscle contraction: Key role of excitation–contraction coupling. J. Physiol. 593, 4713–4727.
Moravec J., Melichar I., Jansky L., Vyskocil F. 1973. Effect of hibernation and noradrenaline on the resting state of neuromuscular junction of golden hamster (Mesocricetus auratus). Pflugers Archiv. 345, 93–106.
Wessler I. 1992. Acetylcholine at motor nerves: Storage, release, and presynaptic modulation by autoreceptors and adrenoceptors. Int. Rev. Neurobiol. 34, 283–384.
Khan M., Lustrinod D., Silveira W.A., Wild F., Straka T., Issop Y., O’Connor E., Cox D., Reischl M., Marquardt T., Labeit D., Labeit S, Benoit E., Molgó J., Lochmüller H., Witzemann V., Kettelhut I.C., Navegantes L.C., Pozzan T., Rudolf R. 2016. Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease. Proc. Natl. Acad. Sci. USA. 113, 746–750.
Kuba K., Tomita T. 1972. Effects of noradrenaline on miniature end-plate potentials and on end-plate potential. J. Theor. Biol. 36, 81–88.
Jenkinson D.H., Stamenovi B.A., Whitaker B. 1968. The effect of noradrenaline on the end-plate potential in twitch fibres of the frog. J. Physiol. 195, 743–754.
Lim S., Muir T. 1983. Microelectrode recording of the effects of agonists and antagonists on alpha-adrenoceptors on rat somatic nerve terminals. Br. J. Pharmacol. 80, 41–46.
Wessler J., Anschuetz S. 1988. Beta-adrenoreceptor stimulation enhances transmitter output from the rat phrenic nerve. Br. J. Pharmacol. 94, 669–674.
Yawo H. 1996. Noradrenaline modulates transmitter release by enhancing the Ca2+ sensitivity of exocytosis in the chick ciliary presynaptic terminal. J Physiol. Lond. 493, 385–391.
Van der Kloot W., Van der Kloot T.E. 1986. Catecholamines, insulin and ACTH increase quantal size at the frog neuromuscular junction. Brain Research. 376, 378–381.
Koketsu K., Miyagawa M., Akasu T., 1982. Catecholamine modulates nicotinic ACh-receptor sensitivity. Brain Research. 236, 487–491.
Sabatini W., Regehr W. 1999. Timing of synaptic transmission. Annu. Rev. Physiol. 61, 521–542.
Lin J.-W., Faber S. 2002. Modulation of synaptic delay during synaptic plasticity. Trends Neurosci. 25, 449–455.
Bukharaeva E., Nikolskii E. 2012. Changes in the kinetics of evoked secretion of transmitter quanta – an effective mechanism modulating the synaptic transmission of excitation. Neurosci. Behav. Physiol. 42, 153–160.
Bukcharaeva E., Kim K., Moravec J., Nikolsky E., Vyskocil F. 1999. Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions. J. Physiol. Lond. 517, 879–888.
Bukharaeva E., Samigullin D., Nikolsky E., Vyskocil F. 2002. Protein kinase A cascade regulates quantal release dispersion at frog muscle endplate. J. Physiol. 538, 837–848.
Kovyazina I., Tsentsevitsky A., Nikolsky E., Bukharaeva E.A. 2010. Kinetics of acetylcholine quanta release at the neuromuscular junction during high-frequency nerve stimulation. Eur. J. Neurosci. 32, 1480–1489.
Tsentsevitsky A., Kovyazina I., Nikolsky E., Bukharaeva E., Giniatullin R. 2013. Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction. Neurosci. 248, 699–707.
Kozachuk W., Phillis J. 1977. The role of calcium ions in noradrenaline-facilitated hyperpolarization on frog skeletal muscle. Gen. Pharmacol. 9, 235–238.
Bergman H., Glusman S., Harris-Warrick R.M., Kravitz E.A., Nussinovitch I., Rahamimoff R. 1991. Noradrenaline augments tetanic potentiation of transmitter release by a calcium dependent process. Brain Res. 214, 200–204.
Dodge F., Rahamimoff R. 1967. Cooperative action of calcium ions in transmitter release at the neuromuscular junctions. J. Physiol. Lond. 193, 419–432.
Vasin A., Samigullin D., Bukharaeva E. 2010. The role of calcium in modulation of the kinetics of synchronous and asynchronous quantal release at the neuromuscular junction. Biochemistry (Moscow) Suppl. Series A: Membr. Cell Biol. 4, 77–84.
Fitzgerald P.J. 2013. Elevated norepinephrine may be an etiological factor in a wide range of diseases: Age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome. Med. Hypotheses. 80, 558–563.
Ghasemi M., Mehranfard N. 2018. Mechanisms underlying anticonvulsant and proconvulsant actions of norepinephrine. Neuropharmacology. 137, 297–308.
Ghazanfari N., Morsch M., Tse N., Reddel S.W., Phillips W.D. 2014. Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. PLoS ONE. 9 (2), e87840. doi 10.1371
Paik H., Chung A., Park H. 2015. Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records. Sci. Rep. 5, 8580–8585.
ACKNOWLEDGMENTS
The authors thank Dr. Victor Ilyin for critical reading and helpful comments on the manuscript. The work was supported by the Russian Science Foundation (project no. 18-15-00046).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All procedures were performed in accordance with the European Communities Council Directive (November 24, 1986; 86/609/EEC) and the Declaration on humane treatment of animals. The Protocol of experiments was approved by the Commission on Bioethics of Kazan State Medical University.
Additional information
The article was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Tsentsevitsky, A.N., Kovyazina, I.V., Bukharaeva, E.A. et al. Effect of Noradrenaline on the Kinetics of Evoked Acetylcholine Secretion in Mouse Neuromuscular Junction. Biochem. Moscow Suppl. Ser. A 12, 327–332 (2018). https://doi.org/10.1134/S1990747818070012
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747818070012